MINIMALLY INVASIVE CABG MUST BE ADAPTED TO MULTI-VESSEL PROCEDURES TO GAIN WIDESPREAD USE, RESEARCHER SAYS; STUDIES AT AHA SUPPORT COST-EFFECTIVENESS
This article was originally published in The Gray Sheet
Executive Summary
The future of minimally invasive coronary artery bypass grafting for coronary artery disease may depend on the treatment's applicability in double- and triple-bypass operations, James Magovern, MD, Allegheny General Hospital, Pittsburgh, Pennsylvania, said during a Nov. 11 press conference at the American Heart Association scientific sessions in New Orleans.